Safety and PK Study of CC-90001 in Subjects With Pulmonary Fibrosis

Study to Evaluate the Safety & Tolerability of MRT5005 Administered by Nebulization in Adults With Cystic Fibrosis

NCT03375047 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

QAX576 in Patients With Pulmonary Fibrosis Secondary to Systemic Sclerosis

NCT00581997 ·Status: TERMINATED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, and Preliminary Pharmacodynamics of QBW251 in Healthy Subjects and Cystic Fibrosis Patients

NCT02190604 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

Study of Denufosol Inhalation Solution in Patients With Mild to Moderate Cystic Fibrosis Lung Disease

NCT00425165 ·Status: TERMINATED ·Phase: PHASE2

Safety Study of Inhaled 552-02 in Cystic Fibrosis Patients

NCT00274313 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study Assessing the Safety, Tolerability, Pharmacokinetics, Food Effect, and Drug-Drug Interactions of PTI-801 in Healthy Volunteers, and Safety, Tolerability, and Pharmacokinetics of PTI-801 in Subjects With Cystic Fibrosis

NCT03140527 ·Status: COMPLETED ·Phase: PHASE1

Safety and Tolerability Study of FG-3019 in Participants With Idiopathic Pulmonary Fibrosis

NCT00074698 ·Status: COMPLETED ·Phase: PHASE1

PK Study of N91115 in Cystic Fibrosis Patients

NCT02227888 ·Status: COMPLETED ·Phase: PHASE1

Phase 1b Safety, Tolerability, and PK Study to Assess GS-5737 in Subjects With CF

NCT01840735 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetic Study of N6022 in Subjects With Cystic Fibrosis Homozygous for the F508del-CFTR Mutation

NCT01746784 ·Status: COMPLETED ·Phase: PHASE1

Bioavailability and Pharmacokinetics Study of FDL169 in Healthy Subjects and Subjects With Cystic Fibrosis

NCT02767297 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study to Assess Efficacy of AZD1236 in Patients With Cystic Fibrosis

NCT00812045 ·Status: WITHDRAWN ·Phase: PHASE2

The Effect of PC945 on Aspergillus Fumigatus Lung Infection in Patients With Cystic Fibrosis

NCT03870841 ·Status: TERMINATED ·Phase: PHASE2

A Phase 1 Trial to Assess the Safety, Tolerability, and Pharmacokinetics of GS 9411 in Subjects With Cystic Fibrosis (CF)

NCT01025713 ·Status: WITHDRAWN ·Phase: PHASE1

Study to Assess the Safety and PK of Oral and IV Xenleta in Adults With Cystic Fibrosis

NCT05225805 ·Status: COMPLETED ·Phase: PHASE1

A Phase II , Placebo-controlled Study to Assess Efficacy of 28 Day Oral AZD9668 in Patients With Cystic Fibrosis

NCT00757848 ·Status: COMPLETED ·Phase: PHASE2

Study of GLPG1837 in Subjects With Cystic Fibrosis (S1251N Mutation)

NCT02690519 ·Status: COMPLETED ·Phase: PHASE2

Testing Drug Efficacy in Cystic Fibrosis Through N-of-1 Trials

NCT04580368 ·Status: RECRUITING ·Phase: NA

A Study to Evaluate Safety, PK and PD of FDL169 in Cystic Fibrosis Subjects

NCT03093714 ·Status: COMPLETED ·Phase: PHASE1

A Drug-Drug Interaction Study of FDL169 and FDL176 in Healthy Subjects

NCT03516331 ·Status: COMPLETED ·Phase: PHASE1

A Study to Determine the Variability of a 6-Minute Walk Test in Cystic Fibrosis Subjects With Advanced Lung Disease

NCT00311506 ·Status: COMPLETED

A Study to Assess the Safety, Tolerability and PK Profile of FDL176 in Healthy and CF Participants

NCT03173573 ·Status: COMPLETED ·Phase: PHASE1

Dose Escalation Study of QR-010 in Homozygous ΔF508 Cystic Fibrosis Patients

NCT02532764 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study to Assess the Safety, Tolerability, and Pharmacokinetics of Brensocatib Tablets in Adults With Cystic Fibrosis

NCT05090904 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic Fibrosis

NCT06429176 ·Status: RECRUITING ·Phase: PHASE2